Enliven Therapeutics, Inc.
ELVN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$89 | -$72 | -$38 | -$25 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$4 |
| Stock-Based Comp. | $20 | $13 | $3 | $2 |
| Change in WC | -$5 | $1 | $0 | $4 |
| Other Non-Cash | -$0 | -$4 | $2 | $4 |
| Operating Cash Flow | -$73 | -$61 | -$32 | -$19 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $35 | $0 |
| Inv. Purchases | -$351 | -$268 | -$35 | -$48 |
| Inv. Sales/Matur. | $314 | $120 | $42 | $46 |
| Other Inv. Act. | $1 | $0 | -$42 | $2 |
| Investing Cash Flow | -$36 | -$148 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $39 | $161 | -$1 | -$1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $94 | $73 | -$1 | $0 |
| Financing Cash Flow | $133 | $234 | -$2 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $24 | $25 | -$34 | -$20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $100 | $76 | $110 | $130 |
| End Cash | $124 | $100 | $76 | $110 |
| Free Cash Flow | -$73 | -$61 | -$33 | -$19 |